BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36820953)

  • 1. ENO1 promotes immunosuppression and tumor growth in pancreatic cancer.
    Huang CK; Lv L; Chen H; Sun Y; Ping Y
    Clin Transl Oncol; 2023 Jul; 25(7):2250-2264. PubMed ID: 36820953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor survival.
    Qiao H; Wang Y; Zhu B; Jiang L; Yuan W; Zhou Y; Guan Q
    J Cell Biochem; 2019 Nov; 120(11):18714-18723. PubMed ID: 31218757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
    Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
    Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis.
    Principe M; Borgoni S; Cascione M; Chattaragada MS; Ferri-Borgogno S; Capello M; Bulfamante S; Chapelle J; Di Modugno F; Defilippi P; Nisticò P; Cappello P; Riganti C; Leporatti S; Novelli F
    J Hematol Oncol; 2017 Jan; 10(1):16. PubMed ID: 28086938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer.
    Zhan P; Zhao S; Yan H; Yin C; Xiao Y; Wang Y; Ni R; Chen W; Wei G; Zhang P
    Mol Carcinog; 2017 May; 56(5):1427-1437. PubMed ID: 27996156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Enolase inhibits apoptosis and promotes cell invasion and proliferation of skin cutaneous melanoma.
    Zhang K; Tian R; Zhang W; Li Y; Zeng N; Liang Y; Tang S
    Mol Biol Rep; 2022 Sep; 49(9):8241-8250. PubMed ID: 35925486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating β-catenin.
    Ji M; Wang Z; Chen J; Gu L; Chen M; Ding Y; Liu T
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31431517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunoregulatory role of alpha enolase in dendritic cell function during Chlamydia infection.
    Ryans K; Omosun Y; McKeithen DN; Simoneaux T; Mills CC; Bowen N; Eko FO; Black CM; Igietseme JU; He Q
    BMC Immunol; 2017 May; 18(1):27. PubMed ID: 28525970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer.
    Huang Z; Yan Y; Wang T; Wang Z; Cai J; Cao X; Yang C; Zhang F; Wu G; Shen B
    J Transl Med; 2022 Jul; 20(1):315. PubMed ID: 35836227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer.
    Cappello P; Rolla S; Chiarle R; Principe M; Cavallo F; Perconti G; Feo S; Giovarelli M; Novelli F
    Gastroenterology; 2013 May; 144(5):1098-106. PubMed ID: 23333712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT signaling pathway.
    Sun L; Lu T; Tian K; Zhou D; Yuan J; Wang X; Zhu Z; Wan D; Yao Y; Zhu X; He S
    Eur J Pharmacol; 2019 Feb; 845():8-15. PubMed ID: 30582908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ENO1-targeted superparamagnetic iron oxide nanoparticles for detecting pancreatic cancer by magnetic resonance imaging.
    Wang L; Yin H; Bi R; Gao G; Li K; Liu HL
    J Cell Mol Med; 2020 May; 24(10):5751-5757. PubMed ID: 32285549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation.
    Zhang G; Zhao X; Liu W
    Cancer Biol Ther; 2022 Dec; 23(1):243-253. PubMed ID: 35316145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest.
    Capello M; Ferri-Borgogno S; Riganti C; Chattaragada MS; Principe M; Roux C; Zhou W; Petricoin EF; Cappello P; Novelli F
    Oncotarget; 2016 Feb; 7(5):5598-612. PubMed ID: 26734996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma.
    Song Y; Luo Q; Long H; Hu Z; Que T; Zhang X; Li Z; Wang G; Yi L; Liu Z; Fang W; Qi S
    Mol Cancer; 2014 Mar; 13():65. PubMed ID: 24650096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-enolase (ENO1), identified as an antigen to monoclonal antibody 12C7, promotes the self-renewal and malignant phenotype of lung cancer stem cells by AMPK/mTOR pathway.
    Shu X; Cao KY; Liu HQ; Yu L; Sun LX; Yang ZH; Wu CA; Ran YL
    Stem Cell Res Ther; 2021 Feb; 12(1):119. PubMed ID: 33579362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis.
    Hu T; Liu H; Liang Z; Wang F; Zhou C; Zheng X; Zhang Y; Song Y; Hu J; He X; Xiao J; King RJ; Wu X; Lan P
    Theranostics; 2020; 10(9):4056-4072. PubMed ID: 32226539
    [No Abstract]   [Full Text] [Related]  

  • 19. Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis.
    Yang T; Shu X; Zhang HW; Sun LX; Yu L; Liu J; Sun LC; Yang ZH; Ran YL
    Cell Death Dis; 2020 Oct; 11(10):870. PubMed ID: 33067426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival.
    Curcio C; Rosso T; Brugiapaglia S; Guadagnin G; Giordano D; Castellino B; Satolli MA; Spadi R; Campra D; Moro F; Papotti MG; Bertero L; Cassoni P; De Angelis C; Langella S; Ferrero A; Armentano S; Bellotti G; Fenocchio E; Nuzzo A; Ciccone G; Novelli F
    Clin Exp Med; 2023 Dec; 23(8):5089-5100. PubMed ID: 37910256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.